Psoriatic Arthritis

Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis
Xintong Li, Kathleen M Andersen, Hsien-Yen Chang, Jeffrey R Curtis, G Caleb Alexander

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216102; DOI: 10.1136/annrheumdis-2019-216102
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019
Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, Gerd R Burmester, Philip J Mease, Leslie Crofford, Vivian Bykerk, Maxime Dougados, James Todd Rosenbaum, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N Cronstein, Ferry C Breedveld, Joachim Kalden, Josef S Smolen, Daniel Furst

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216151; DOI: 10.1136/annrheumdis-2019-216151
Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
Richard James Cuthbert, Abdulla Watad, Evangelos M Fragkakis, Robert Dunsmuir, Peter Loughenbury, Almas Khan, Peter A Millner, Adam Davison, Helena Marzo-Ortega, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1559-1565; DOI: 10.1136/annrheumdis-2019-215210
Incidence and time trends of joint surgery in patients with psoriatic arthritis: a register-based time series and cohort study from Denmark
Jørgen Guldberg-Møller, Rene Lindholm Cordtz, Lars Erik Kristensen, Lene Dreyer

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1517-1523; DOI: 10.1136/annrheumdis-2019-215313
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Philip J Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu-Seifert, Paul Emery, Sreekumar G Pillai, Philip S Helliwell

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-215386; DOI: 10.1136/annrheumdis-2019-215386
Early identification of rheumatoid arthritis: the risk of overtreatment in perspective
Annette van der Helm-van Mil

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e107; DOI: 10.1136/annrheumdis-2018-214156
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
Dennis G McGonagle, Iain B McInnes, Bruce W Kirkham, Jonathan Sherlock, Robert Moots

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1167-1178; DOI: 10.1136/annrheumdis-2019-215356
The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies
Arthur Kavanaugh, Alice Gottlieb, Akimichi Morita, Joseph F Merola, Chen-Yen Lin, Julie Birt, Catherine L Shuler, Matthew M Hufford, Diamant Thaçi

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1215-1219; DOI: 10.1136/annrheumdis-2018-215003
Are the loading dose treatment groups superior to the 150 mg without loading dose group in the secukinumab FUTURE 5 study?
Bernardo Matos da Cunha

Annals of the Rheumatic Diseases Sep 2019, 78 (9) e97; DOI: 10.1136/annrheumdis-2018-213770
DAPSA versus cDAPSA: Do we need to use CRP?
Rafaela Silva Guimarães Gonçalves, Lays Miranda de Almeida Martins, Henrique de Ataide Mariz, Andrea Tavares Dantas, Angela Luzia Branco Pinto Duarte

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215960; DOI: 10.1136/annrheumdis-2019-215960

Main menu

Psoriatic Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Psoriatic Arthritis

Pages